Report on the Drug Situation 2010 - Bundesministerium fÃ¼r ...

More documents

Recommendations

Info

Figure 5.7 First substitution treatment in life, by age, 2000–2009 Persons treated 3 000 2 800 2 600 2 400 2 200 2 000 1 800 1 600 1 400 1 200 1 000 800 600 400 200 0 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 Year 19 or younger 20–24 25–29 30–34 35–39 40–44 Over 44 Source: BMG, calculation and representation by GÖG/ÖBIG Caution is advised when analysing the substances prescribed for first treatment, as part of the treatments, due to the reasons mentioned above, might incorrectly have been entered as first treatments. The share of slow-release morphines has again slightly risen compared to previous years: to 33% (2008: 25%). The prescription rates of methadone, buprenorphine and Suboxone have gone down insignificantly (see Figure 5.8). As in past years, the analyses of the DOKLI data show a different picture. One has to bear in mind here that the respective data are comparable to a limited extent only (different groups of clients; see GÖG/ÖBIG 2007b). In the case of clients registered by DOKLI, slow-release morphines are prescribed most often (45% of longterm outpatient clients; 67% of clients receiving low-threshold services and 62% of persons undergoing long-term inpatient treatment), and the share of substitution patients who are administered methadone is between 17% and 27%, while buprenorphine is taken by only 5% to 21% of patients (GÖG/ÖBIG 2010a). Buprenorphine is typically prescribed to younger clients. 52 © GÖG/ÖBIG, <strong>Report</strong> on the Drug Situation 2010
Figure 5.8 Trends regarding substitution substances used for first treatment, 2000–09, percentages 100 90 80 70 60 50 40 30 20 10 0 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 Methadone Buprenorphine Slow-release morphines Codidol Suboxone Source: BMG, calculation and representation by GÖG/ÖBIG Due to the aforementioned problems regarding data quality of the substitution registry it has not been regarded as sensible to update the estimate presented in last year’s report of the total number of people undergoing drug related treatment based on DOKLI and OST data (the result for 2008 is given in GÖG/ÖBIG 2009b: 17 000 persons). It is safe to assume, however, that the respective figures will not have changed significantly within one year. Chapter 5 / Drug-related Treatment: Treatment Demand and Treatment Availability 53
Page 1:
Report on the Drug
Page 4 and 5:
ISBN-13 978-3-85159-153-8 Owner, ed
Page 6 and 7:
Prevention The trend towards drawin
Page 8 and 9:
hardly known. This makes it impossi
Page 10 and 11:
6 Health Correlates and Consequence
Page 12 and 13:
Tables and Figures Tables Table 6.1
Page 14 and 15:
Table A22 Table A23 Table A24 Table
Page 16 and 17:
Figure 9.1 Figure 9.2 Figure 9.3 Fi
Page 19: Part A New Developments and Trends
Page 22 and 23: The amendment to the Narcotic Drugs
Page 24 and 25: deaths (see GÖG/ÖBIG 2009b) conti
Page 26 and 27: In the reporting period, no new dev
Page 28 and 29: 2.1 Drug use in the general populat
Page 30 and 31: The quitting rate 3 is considerably
Page 32 and 33: Figure 2.2 Experience of cannabis u
Page 34 and 35: described on the individual website
Page 36 and 37: ehaviour is elevated for children i
Page 38 and 39: theme of the Gesunde Gemeinden (hea
Page 40 and 41: party scenes are relevant settings.
Page 42 and 43: support if needed. The project is i
Page 44 and 45: approximations and have to be inter
Page 46 and 47: Figure 4.2 2-sample CRC estimates w
Page 48 and 49: 5 Drug-related Treatment: Treatment
Page 50 and 51: 2010, now 50 doctors are entitled t
Page 52 and 53: patients for inpatient treatment al
Page 54 and 55: Map 5.2 Specialised providers of ou
Page 56 and 57: cooperation structures linking the
Page 58 and 59: events are organised, and on the ot
Page 60 and 61: 5.3 Characteristics of treated clie
Page 62 and 63: play the most important role in the
Page 64 and 65: existing treatment system who do no
Page 66 and 67: 5.4 Trends of clients in treatment
Page 70 and 71: 6 Health Correlates and Consequence
Page 72 and 73: Table 6.1 Data on hepatitis B, hepa
Page 74 and 75: ange from affective disorders (e.g.
Page 76 and 77: Figure 6.1 Share of directly drug-r
Page 78 and 79: In the EMCDDA working group on coho
Page 80 and 81: 7 Responses to Health Correlates an
Page 82 and 83: 7.2 Prevention and treatment of dru
Page 84 and 85: distribution of condoms) is provide
Page 86 and 87: information on the risks of additio
Page 88 and 89: While smaller shares of women state
Page 90 and 91: Map 8.1 Specialised providers of in
Page 92 and 93: The Lighthouse housing project of M
Page 94 and 95: empowerment that had been aimed at,
Page 96 and 97: handling of drugs: Section 27 of th
Page 98 and 99: also shows regarding prison sentenc
Page 100 and 101: Stadtpark, and Westbahnhof station.
Page 102 and 103: mation on final convictions because
Page 104 and 105: practitioners and psychiatrists). I
Page 106 and 107: 10 Drug Markets The substance most
Page 108 and 109: head shop in Graz (Styria) in Augus
Page 110 and 111: (from 2005 to 2008, the correspondi
Page 113: Part B Selected Issues
Page 116 and 117: national quality standards for medi
Page 118 and 119:
Also, both at federal and provincia
Page 120 and 121:
Table 11.1, continued Title and yea
Page 122 and 123:
Plans for new guidelines and standa
Page 124 and 125:
12 Cost of Drug-related Treatment T
Page 126 and 127:
centres so far (Schweizer Haus Hade
Page 128 and 129:
greatest percentage of the respecti
Page 130 and 131:
(e.g., days of hospital stay becaus
Page 133 and 134:
Bibliography APA 2010. AIDS 2010. W
Page 135 and 136:
EMCDDA 2000. Treatment demand indic
Page 137 and 138:
Haas, S. (2005). Problembewusste Fr
Page 139 and 140:
Pont, J.; Wool, R. (2006). Ein Leit
Page 141 and 142:
VIVID 2010. Jahresbericht 2009. VIV
Page 143 and 144:
Personal Communications (alphabetic
Page 145 and 146:
Caritas Marienambulanz. Drug relate
Page 147 and 148:
Low threshold service Ganslwirt (Ve
Page 149 and 150:
Viennese pilot project “Pregnancy
Page 151 and 152:
Lower Austria: Fachstelle für Such
Page 153 and 154:
Caritas Innsbruck http://www.carita
Page 155 and 156:
Otto-Wagner-Spital — Drogeninstit
Page 157:
Annex A. Tables, Map B. List of Abb
Page 161 and 162:
Table A1 Overview of selected gener
Page 163 and 164:
Table A2, continued Study (author(s
Page 165 and 166:
Table A5 Number of directly drug-re
Page 167 and 168:
Table A7 Distribution of directly d
Page 169 and 170:
Table A11 Distribution of reports o
Page 171 and 172:
Table A15 Final convictions under t
Page 173 and 174:
Table A18 Seizures of narcotic drug
Page 175 and 176:
Table A22 Persons starting drug tre
Page 177 and 178:
Page 179 and 180:
Page 181 and 182:
Table A29 Current health problems o
Page 183 and 184:
The programme plus is implemented i
Page 185 and 186:
Proven regional interventions run f
Page 187 and 188:
Table A34 Austrian population stati
Page 189:
Annex B List of Abbreviations
Page 192 and 193:
HCV HCV-Ab HCV-RNA HIV ICD-10 IFES
Page 195 and 196:
List of Standard Tables of 2010 and
Page 197:
© Gesundheit Österreich GmbH Stub
show all

Report on the Drug Situation 2010 - Bundesministerium fÃ¼r ...

Create successful ePaper yourself

Delete template?

Save as template?